Your browser doesn't support javascript.
loading
Hypoxia activates the hypoxia-inducible factor-1α/vascular endothelial growth factor pathway in a prostatic stromal cell line: A mechanism for the pathogenesis of benign prostatic hyperplasia.
Zhang, Tao; Mao, Changlin; Chang, Yao; Lyu, Jiaju; Zhao, Delong; Ding, Sentai.
Afiliación
  • Zhang T; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Mao C; Department of Urology, Mindong Hospital Affiliated to Fujian Medical University, Fuan, China.
  • Chang Y; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Lyu J; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Zhao D; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
  • Ding S; Department of Urology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Curr Urol ; 18(3): 185-193, 2024 Sep.
Article en En | MEDLINE | ID: mdl-39219634
ABSTRACT

Background:

The development of benign prostatic hyperplasia (BPH) is closely related to hypoxia in the prostatic stroma, and the hypoxia-inducible factor-1α/vascular endothelial growth factor (HIF-1α/VEGF) pathway has been shown to significantly activate in response to hypoxia. The underlying mechanism for activation of this pathway in the pathogenesis of BPH remains unclear. Materials and

methods:

We constructed HIF-1α overexpression and knockdown BPH stromal (WPMY-1) and epithelial (BPH-1) cell lines, which were cultured under different oxygen conditions (hypoxia, normoxia, and hypoxia + HIF-1α inhibitor). Quantitative real-time polymerase chain reaction (qPCR) and Western blotting were applied to detect the expression of the HIF-1α/VEGF pathway. Cell proliferation and apoptosis were analyzed by Cell Counting Kit-8 and flow cytometry. We used the miRWalk 2.0 database and Western blotting to predict the potential miRNA that selectively targets the HIF-1α/VEGF pathway, and verified the prediction by qPCR and dual-luciferase assays.

Results:

In a BPH stromal cell line (WPMY-1), the expression of VEGF was in accordance with HIF-1α levels, elevated in the overexpression cells and decreased in the knockdown cells. Hypoxia-induced HIF-1α overexpression, which could be reversed by a HIF-1α inhibitor. Moreover, the HIF-1α inhibitor significantly depressed cellular proliferation and promoted apoptosis in hypoxic conditions, assessed by Cell Counting Kit-8 and flow cytometry. However, in the BPH epithelial cell line (BPH-1), the expression level of HIF-1α did not influence the expression of VEGF. Finally, a potential miRNA, miR-17-5p, regulating the HIF-1α/VEGF pathway was predicted from the miRWalk 2.0 database and Western blotting, and verified by qPCR and dual-luciferase assay.

Conclusions:

In hypoxia, activation of the HIF-1α/VEGF pathway plays a crucial role in regulating cell proliferation in a BPH stromal cell line. Regulation by miR-17-5p may be the potential mechanism for the activation of this pathway. Regulation of this pathway may be involved in the pathogenesis of BPH.
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Curr Urol Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Idioma: En Revista: Curr Urol Año: 2024 Tipo del documento: Article